Target Name: MIR4733
NCBI ID: G100616266
Other Name(s): hsa-mir-4733 | hsa-miR-4733-5p | MicroRNA 4733 | microRNA 4733 | hsa-miR-4733-3p

MIR4733: A Potential Drug Target and Biomarker

MIR4733 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR family of non-coding RNA-binding proteins, which are known for their ability to interact with RNA molecules and play important roles in various cellular processes. In recent years, researchers have become increasingly interested in MIR4733 due to its potential as a drug target and biomarker.

The discovery and characterization of MIR4733 comes from a study by the research group of Dr. Qin Liu at the University of California, San Diego. In this study, the researchers used a variety of techniques, including RNA interference, RNA sequencing, and mass spectrometry, to investigate the effects of MIR4733 on cellular processes and identify its potential as a drug target.

One of the main findings of the study was that MIR4733 was shown to be involved in the regulation of cell apoptosis, which is a natural process that helps the body remove damaged or dysfunctional cells. The researchers found that MIR4733 was shown to promote the survival of cells under conditions that would normally cause them to apoptose. This suggests that MIR4733 may have potential as a drug target for diseases that are characterized by uncontrolled cell growth or apoptosis.

Another finding of the study was that MIR4733 was shown to be involved in the regulation of cell proliferation. The researchers found that MIR4733 inhibited the proliferation of cells under conditions that would normally promote cell growth, suggesting that it may have potential as a drug target for diseases that are characterized by uncontrolled cell growth.

In addition to its potential as a drug target, MIR4733 also has potential as a biomarker. The researchers found that MIR4733 was highly expressed in various tissues of the brain and that it was downregulated in the brains of mice with neurodegenerative diseases. This suggests that MIR4733 may be a useful biomarker for tracking the progression of these diseases and identifying potential therapeutic targets.

Overall, the findings of the study suggest that MIR4733 is a promising drug target and biomarker with potential for the development of new therapies for a variety of diseases. Further research is needed to fully understand the effects of MIR4733 and to identify its potential clinical applications.

Protein Name: MicroRNA 4733

More Common Targets

MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A